6-1611782-ACGGCGGCGGCGG-ACGGCGGCGGCGGCGG
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001453.3(FOXC1):c.1359_1361dupCGG(p.Gly454dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.238 in 1,439,242 control chromosomes in the GnomAD database, including 27,814 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.28 ( 5705 hom., cov: 19)
Exomes 𝑓: 0.23 ( 22109 hom. )
Consequence
FOXC1
NM_001453.3 disruptive_inframe_insertion
NM_001453.3 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.613
Genes affected
FOXC1 (HGNC:3800): (forkhead box C1) This gene belongs to the forkhead family of transcription factors which is characterized by a distinct DNA-binding forkhead domain. The specific function of this gene has not yet been determined; however, it has been shown to play a role in the regulation of embryonic and ocular development. Mutations in this gene cause various glaucoma phenotypes including primary congenital glaucoma, autosomal dominant iridogoniodysgenesis anomaly, and Axenfeld-Rieger anomaly. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 6-1611782-A-ACGG is Benign according to our data. Variant chr6-1611782-A-ACGG is described in ClinVar as [Benign]. Clinvar id is 93747.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.399 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXC1 | NM_001453.3 | c.1359_1361dupCGG | p.Gly454dup | disruptive_inframe_insertion | 1/1 | ENST00000645831.2 | NP_001444.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXC1 | ENST00000645831.2 | c.1359_1361dupCGG | p.Gly454dup | disruptive_inframe_insertion | 1/1 | NM_001453.3 | ENSP00000493906.1 |
Frequencies
GnomAD3 genomes AF: 0.283 AC: 40439AN: 142866Hom.: 5695 Cov.: 19
GnomAD3 genomes
AF:
AC:
40439
AN:
142866
Hom.:
Cov.:
19
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.240 AC: 15558AN: 64810Hom.: 826 AF XY: 0.235 AC XY: 8867AN XY: 37658
GnomAD3 exomes
AF:
AC:
15558
AN:
64810
Hom.:
AF XY:
AC XY:
8867
AN XY:
37658
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.233 AC: 301476AN: 1296298Hom.: 22109 Cov.: 33 AF XY: 0.231 AC XY: 147705AN XY: 639150
GnomAD4 exome
AF:
AC:
301476
AN:
1296298
Hom.:
Cov.:
33
AF XY:
AC XY:
147705
AN XY:
639150
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.283 AC: 40485AN: 142944Hom.: 5705 Cov.: 19 AF XY: 0.284 AC XY: 19767AN XY: 69530
GnomAD4 genome
AF:
AC:
40485
AN:
142944
Hom.:
Cov.:
19
AF XY:
AC XY:
19767
AN XY:
69530
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 09, 2014 | - - |
Axenfeld-Rieger syndrome type 3 Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Anterior segment dysgenesis 3 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at